ATE315667T1 - Amplifizierung und detektion von hiv-1 und/oder hiv-2 - Google Patents

Amplifizierung und detektion von hiv-1 und/oder hiv-2

Info

Publication number
ATE315667T1
ATE315667T1 AT98304959T AT98304959T ATE315667T1 AT E315667 T1 ATE315667 T1 AT E315667T1 AT 98304959 T AT98304959 T AT 98304959T AT 98304959 T AT98304959 T AT 98304959T AT E315667 T1 ATE315667 T1 AT E315667T1
Authority
AT
Austria
Prior art keywords
hiv
amplification
detection
subtypes
type
Prior art date
Application number
AT98304959T
Other languages
English (en)
Inventor
John Wesley Backus
Susan Melissa Atwood
Ann Elizabeth Casey
Eric Brice Rasmussen
Thomas Joseph Cummins
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE315667T1 publication Critical patent/ATE315667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98304959T 1997-06-25 1998-06-24 Amplifizierung und detektion von hiv-1 und/oder hiv-2 ATE315667T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5075997P 1997-06-25 1997-06-25

Publications (1)

Publication Number Publication Date
ATE315667T1 true ATE315667T1 (de) 2006-02-15

Family

ID=21967243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98304959T ATE315667T1 (de) 1997-06-25 1998-06-24 Amplifizierung und detektion von hiv-1 und/oder hiv-2

Country Status (8)

Country Link
US (1) US6001558A (de)
EP (1) EP0887427B1 (de)
JP (1) JP4339427B2 (de)
AT (1) ATE315667T1 (de)
DE (1) DE69833160T2 (de)
DK (1) DK0887427T3 (de)
ES (1) ES2256920T3 (de)
SI (1) SI0887427T1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2479065T3 (es) 1997-08-08 2014-07-23 Biomérieux Bv Métodos de uso de secuencias de ácido nucleico como cebadores y sondas en la amplificación y detección de todos los subtipos de VIH-1
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
FR2786786A1 (fr) * 1998-12-07 2000-06-09 Microdiag Procede et kit pour l'amplification, la detection et/ou la quantification de populations de genomes
US6303293B1 (en) * 1999-02-02 2001-10-16 Ortho-Clinical Diagnostics, Inc. Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
AU3219400A (en) * 1999-02-03 2000-08-25 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and reagents for molecular detection of hiv-1 groups m, n and
US6623919B1 (en) * 1999-02-03 2003-09-23 Ortho-Clinical Diagnostics, Inc Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
AU3438999A (en) * 1999-05-07 2000-11-21 Nationales Zentrum Fur Retroviren Detection system for human immunodeficiency virus based on nucleic acid amplification
ATE456677T1 (de) * 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
DE19950953B4 (de) * 1999-10-23 2004-07-01 Ganser, Arnold, Prof.Dr. Verfahren zur Herstellung lentiviraler Partikel
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
ATE386821T1 (de) 2000-10-23 2008-03-15 Gen Probe Inc Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
JP2004313181A (ja) * 2003-04-02 2004-11-11 Canon Inc 感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
US7255996B2 (en) * 2003-12-19 2007-08-14 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
CN1910289B (zh) * 2004-01-07 2012-05-23 日立化成研究中心公司 用于检测hiv的引物和探针
EP1602736A1 (de) * 2004-06-04 2005-12-07 Bio-Rad Pasteur Detektion von HIV Typen und Subtypen
EP1627563A1 (de) * 2004-08-10 2006-02-22 Academisch Medisch Centrum bij de Universiteit van Amsterdam Verfahren und Mittel zur Herstellung einer stabilisierten Zelle
US9085807B2 (en) 2004-09-14 2015-07-21 Argos Therapeutics, Inc. Strain-independent amplification of pathogens and vaccines thereto
EP1647595A1 (de) * 2004-10-15 2006-04-19 Academisch Medisch Centrum bij de Universiteit van Amsterdam Nukleinsäuren gegen Viren, insbesondere gegen HIV
JP5155176B2 (ja) * 2005-11-17 2013-02-27 ティーイーティー システムズ ゲーエムベーハー ウント ツェーオー． カーゲー 誘導発現系
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
EP1974017B2 (de) 2005-12-09 2023-06-21 Academisch Medisch Centrum bij de Universiteit van Amsterdam Mittel und verfahren zur beeinflussung der stabilität antikörperproduzierender zellen
WO2007067032A1 (en) 2005-12-09 2007-06-14 Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
DE102008025328B4 (de) 2008-05-27 2013-10-17 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von HI-Viren mittels Multiplex-PCR in multiplen Genombereichen
US20100136516A1 (en) * 2008-12-01 2010-06-03 454 Life Sciences Corporation System and method for detection of HIV integrase variants
JP2012510476A (ja) * 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
JP5781508B2 (ja) 2009-07-15 2015-09-24 アイム・セラピューティクス・べー・フェー 高親和性抗体を産生させるための手段および方法
EP2646466B1 (de) 2010-12-02 2017-03-29 AIMM Therapeutics B.V. Mittel und methoden zur produktion von hoch affinen antikörpern
AU2015211480B2 (en) 2014-01-31 2020-05-14 Kling Biotherapeutics B.V. Means and methods for producing stable antibodies
WO2015181627A1 (en) * 2014-05-27 2015-12-03 Universite Paris Descartes In vitro method for the detection and quantification of hiv-2
WO2016073255A1 (en) * 2014-11-06 2016-05-12 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Detection of hiv-1 nucleic acids by reverse-transcription loop-mediated isothermal amplication
US10858711B2 (en) 2015-02-23 2020-12-08 University Of Washington Primers, probes and methods for sensitive, specific detection and monitoring of HIV-1 and HCV
CN104911277B (zh) * 2015-04-14 2018-02-06 广州海力特生物科技有限公司 一种检测干血斑标本中人类免疫缺陷病毒1型的试剂盒及其检测方法
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
ES2944360T3 (es) * 2017-10-03 2023-06-20 Abbott Molecular Inc Ensayo para la detección del virus de la inmunodeficiencia humana (VIH)
TW202126317A (zh) 2019-09-24 2021-07-16 美商普拉塔生技公司 用於治療發炎和免疫疾病之組成物和方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2917150C2 (de) * 1979-04-27 1981-06-11 Blau Kg Fabrik Fuer Kraftfahrzeugteile, 4018 Langenfeld Verschlußdeckel
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
CA1340747C (en) * 1988-06-14 1999-09-14 Karsten Henco Hiv-2 virus variants
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
EP1715064B1 (de) * 1989-06-02 2009-02-25 Institut Pasteur Nukleotid-Sequenzen von HIV-1, HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur Amplifizierung von pol-Sequenzen dieser Retroviren und zur In Vitro Diagnostik von diesen Viren verursachten Infektionen
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
ATE147792T1 (de) * 1989-11-30 1997-02-15 Pharmacia Biotech Ab Neues verfahren zum nachweis einer spezifischen nukleinsäuresequenz in einer zellprobe
IE910081A1 (en) * 1990-01-10 1991-07-17 Chiron Corp The use of DNA-dependent RNA polymerase transcripts as¹reporter molecules for signal amplification in nucleic acid¹hybridization assays
FR2663040B1 (fr) * 1990-06-11 1995-09-15 Bio Merieux Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
GB9016973D0 (en) * 1990-08-02 1990-09-19 Medical Res Council Viral growth inhibition
ES2115622T5 (es) * 1990-10-17 2003-03-16 Us Health Clones moleculares de hiv-1 y usos de los mismos.
GB9125623D0 (en) * 1991-12-02 1992-01-29 Dynal As Cell modification
WO1994023069A1 (en) * 1993-03-26 1994-10-13 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
EP0630973A3 (de) * 1993-05-14 1995-04-26 Eastman Kodak Co Diagnosezusammensetzungen, Elemente, Verfahren und Testkits zur Amplifikation und zum Nachweis von zwei oder mehren DNS und Verwendung von Primern mit angepassten Schmelztemperaturen.
US5576176A (en) * 1994-03-03 1996-11-19 The Regents Of The University Of California Marker and an assay for detection and monitoring of human immunodeficiency virus latency and activation
EP0807172A1 (de) * 1995-01-30 1997-11-19 HYBRIDON, Inc. Transkriptions-inhibitoren des menschlichen immunodefiziens-virus und verfahren zur deren verwendung
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5795722A (en) * 1997-03-18 1998-08-18 Visible Genetics Inc. Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample

Also Published As

Publication number Publication date
EP0887427B1 (de) 2006-01-11
JP4339427B2 (ja) 2009-10-07
JPH1169987A (ja) 1999-03-16
DE69833160D1 (de) 2006-04-06
EP0887427A3 (de) 2001-10-17
DK0887427T3 (da) 2006-05-15
ES2256920T3 (es) 2006-07-16
DE69833160T2 (de) 2006-09-14
SI0887427T1 (sl) 2006-06-30
EP0887427A2 (de) 1998-12-30
US6001558A (en) 1999-12-14

Similar Documents

Publication Publication Date Title
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
NO20000513L (no) Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
TR199801418T2 (xx) Rekombinant a�� vekt�rleri kar���m�.
DE69627408D1 (de) Primers und Sonden zum Nachweis von HIV
ES2194029T3 (es) Variantes del virus hiv-2.
DE69804464D1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
DE69836395D1 (de) Primern zum Nachweis von HIV-1
ATE386821T1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
NO20014841L (no) Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet
ATE422544T1 (de) Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen
NO20000514L (no) Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav
CA2195125A1 (en) Difluorostatone antiviral agents
DE3877212D1 (de) Antivirale anwendung von alpha-oligonucleotiden.
DE69723456D1 (de) 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren
ATE198602T1 (de) Makrocyclische difluorostatonderivate als antivirale mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0887427

Country of ref document: EP